Company: GANX
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001558370-25-003823
Chunk: 39

Company: Gain Therapeutics, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 15E
Chunk 39
---
​

​​​​Incorporated by ReferenceExhibitNumber    Exhibit    Form    File No.    Exhibit    Filing Date​​​​​​​​​​​3.1​Amended and Restated Certificate of Incorporation of Gain Therapeutics, Inc.​8-K​001-40237​3.1​3/17/20213.2​Amended and Restated Bylaws of Gain Therapeutics, Inc.​8-K​001-40237​3.2​3/17/20214.1*​Description of Securities. ​​​​​​​​4.2​Investors’ Rights Agreement, dated as of July 20, 2020, by and among Gain Therapeutics, Inc. and certain holders of its capital stock.​S-1​333-253303​4.2​2/19/20214.3​Form of Warrant. ​8-K​001-40237​4.1​11/22/20234.4​Form of Private Warrant.​8-K​001-40237​4.2​11/22/20234.5​Form of Underwriter’s Warrant.​8-K​001-40237​4.3​11/22/20234.6​Form of Pre-Funded Warrant.​8-K​001-40237​4.4​11/22/20234.7​Warrant Agent Agreement by and between Gain Therapeutics, Inc. and Pacific Stock Transfer Company.​8-K​001-40237​4.5​11/22/20234.8​Form of Placement Agent Warrant.​8-K​001-40237​4.6​11/22/202310.1+​Form of Indemnification Agreement for Officers and Directors.​S-1/A​333-253303​10.2​3/10/202110.2+​2020 Omnibus Incentive Plan.​S-1/A​333-253303​10.1​3/10/202110.3+​Gain Therapeutics, Inc. 2021 Inducement Equity Incentive Plan. ​8-K​001-40237​10.1​12/28/202110.4+​Form of Stock Option Agreement under the 2021 Inducement Plan.​8-K​001-40237​10